Mode
Text Size
Log in / Sign up
N/A N=16 Treatment

Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning

Persistent Depressive Disorder

Enrolled (actual)
16
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Paid Work Hours at Week 12 — 30.3 hours — p=0.005

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Behavioral Activation for return to work (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
New York State Psychiatric Institute
Primary completion
Dec 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Paid Work Hours at Week 12
30.3 0.005 sig
PRIMARY
Paid Work Hours at Week Baseline
16.9
SECONDARY
Social Functioning at Week Baseline on the Social Adjustment Scale
2.4 0.11
SECONDARY
Social Functioning at Week 12 on the Social Adjustment Scale
2.18

Summary

The investigators aimed to assess the ability of a modified version of Behavioral Activation for occupational and social improvement to produce change in: 1. social adjustment, 2. work functioning, 3. avoidance behavior and 4. behavioral activation.

Eligibility Criteria

Inclusion Criteria

  • adults aged 20-75 years
  • a primary diagnosis of Dysthymic Disorder, Chronic major depressive disorder or double depression
  • a >50% decrease in 17 item Hamilton Rating Scale for Depression (HRSD-17) score and a final HRSD-17 score ≤ 10 with an adequate antidepressant medication (ADM) trial (> 4 weeks on at least 50% Physician's Desk Reference maximum ADM dose)
  • a rating of 1 ("very much improved") or 2 ("much improved") on the Clinical Global Impressions-Improvement scale (CGI-I)
  • continued functional impairment, defined by scores >1.9 on the Social Adjustment Scale (SAS)
  • unemployment (jobless, looking for work) according to the Bureau of Labor Statistics: jobless and looking and available for work, or underemployed.

Exclusion Criteria

  • Structured Clinical Interview for Diagnostic and Statistical Manual, fourth edition (DSM-IV) Axis I disorders-diagnosed cognitive or psychotic disorders
  • bipolar disorder
  • active eating disorders
  • severe borderline personality disorder
  • alcohol or drug dependence (except nicotine) in the last 6 months
  • current suicide risk
  • unstable medical conditions
  • use of psychotropic medications other than antidepressants
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01783080). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search